- This conference will be a virtual event -

Overview

OPN ASH Review is a focused educational program designed specifically for pharmacists, highlighting key scientific updates and clinical advancements presented at the ASH Annual Meeting. This program translates emerging hematology data into practical, pharmacy-driven insights that support safe, effective, and evidence-based patient care.

The sessions feature targeted reviews of high-impact abstracts and studies in malignant and benign hematology, with an emphasis on therapeutic decision-making, toxicity management, and medication-related considerations. Expert faculty will interpret the latest findings, discuss implications for current standards of care, and provide guidance on how pharmacists can apply these data in real-world clinical practice.

Through a virtual, interactive format, the program will reinforce the pharmacist’s role in optimizing treatment outcomes, managing complex therapies such as cellular and immunotherapies, and collaborating within multidisciplinary teams across care settings.

Industry Employee** registration is date-based pricing +$400

*Student is defined as currently enrolled in an advanced learning institution and/or studying in order to enter a particular profession.

If you would like to attend as a Student, please contact [email protected] for further information.

**Defined as anyone employed by a drug, device, or diagnostic company. The primary goal of the conference is to educate practicing clinicians on the latest advances and strategies in the care of cancer patients. Because space is limited and to ensure sufficient seats are available for clinicians, Industry Employees may register as an attendee only if you have a clinical title (NP, PharmD, MD, PA, etc).

Learning Objectives

1. Assess the latest clinical data and emerging research findings on the diagnosis and workup of hematologic malignancies and blood disorders
2. Identify advances in disease staging, risk stratification, and biomarker-driven evaluation relevant to clinical decision-making
3. Describe current challenges and clinical considerations in managing patients with hematologic malignancies, including transplantation, cellular therapies, and anticoagulation
4. Discuss best practices and evidence-based pharmacotherapy strategies for managing complex patient cases in hematologic oncology
5. Select evidence-based pharmacologic therapies to optimize treatment selection and patient outcomes

Target Audience

This conference is planned with and for hematology/oncology pharmacy clinicians. This includes pharmacists, pharmacy techs, and other healthcare professionals involved in hematology/oncology pharmacy.

Presented By